Scribe Therapeutics annual revenue
2024
2025
Scribe Therapeutics Revenue Growth & History (SCTX)
Scribe Therapeutics reported $51.2M in revenue for fiscal 2025, an increase of 86.68% from the previous fiscal year.
View full Scribe Therapeutics company overviewScribe Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $51.2M | $23.8M | +86.68% |
| 2024 | 2024-12-31 | $27.4M | — | — |
Scribe Therapeutics quarterly revenue
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.9M | −$3.0M | −60.84% |
| Q1 2026 | 2026-03-31 | $2.2M | −$14.9M | −86.96% |
| Q2 2025 | 2025-06-30 | $4.9M | — | — |
| Q1 2025 | 2025-03-31 | $17.1M | — | — |
Scribe Therapeutics revenue growth trends
Scribe Therapeutics's latest reported quarter, Q2 2026, generated $1.9M in revenue, a decrease of 60.84% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Scribe Therapeutics source filings ↗